Sarcoid iridocyclitis
ICD-10 D86.83 is a billable code used to indicate a diagnosis of sarcoid iridocyclitis.
Sarcoid iridocyclitis is an inflammatory condition affecting the iris and ciliary body of the eye, associated with systemic sarcoidosis. Sarcoidosis is a granulomatous disease characterized by the formation of non-caseating granulomas in various organs, including the lungs, skin, and lymph nodes. In the eye, sarcoid iridocyclitis manifests as inflammation of the uveal tract, leading to symptoms such as redness, pain, blurred vision, and photophobia. The condition can result in complications such as glaucoma, cataracts, and vision loss if not managed appropriately. Diagnosis typically involves a comprehensive eye examination, imaging studies, and sometimes biopsy of affected tissues to confirm the presence of granulomas. Treatment often includes corticosteroids to reduce inflammation and manage symptoms, and in some cases, immunosuppressive therapy may be necessary. Regular follow-up is crucial to monitor for potential complications and adjust treatment as needed.
Detailed eye examination findings, including visual acuity and intraocular pressure measurements.
Patients presenting with eye pain, redness, and blurred vision.
Documentation must clearly indicate the relationship between sarcoidosis and ocular symptoms.
Comprehensive assessment of systemic sarcoidosis, including organ involvement and treatment history.
Patients with known sarcoidosis presenting with new ocular symptoms.
Coordination with ophthalmology for accurate diagnosis and management.
Used when a new patient presents with symptoms of iridocyclitis.
Document the examination findings and any diagnostic tests performed.
Ophthalmologists should ensure thorough documentation of systemic disease.
The primary treatment involves corticosteroids to reduce inflammation, with immunosuppressive therapy considered for severe cases.
